Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer

M. K. Mistulova, V. A. Gerasin, S. V. Orlov, L. V. Stelmakh, T. V. Bigday (St.Petersburg, Russia)

Source: Annual Congress 2001 - Therapy for non-small cell lung cancer
Session: Therapy for non-small cell lung cancer
Session type: Poster Discussion
Number: 2587
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. K. Mistulova, V. A. Gerasin, S. V. Orlov, L. V. Stelmakh, T. V. Bigday (St.Petersburg, Russia). Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer. Eur Respir J 2001; 16: Suppl. 31, 2587

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Radiotherapy in the treatment of nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 207–243
Year: 2009

Surgical treatment of nonsmall cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=170
Year: 2001

Combined radiotherapy for nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 31s
Year: 2003

The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Targeted therapy in non-small cell lung cancer
Source: Breathe 2012; 8: 206-215
Year: 2012

Use of 2nd-line polychemotherapy in advanced nonsmall cell lung cancer – a reasonable approach
Source: Eur Respir J 2003; 22: Suppl. 45, 65s
Year: 2003

Towards personalized treatment in non-small-cell lung carcinoma
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020


Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010

Surgical and nonsurgical approaches to small-size nonsmall cell lung cancer
Source: Eur Respir J 2014; 44: 483-494
Year: 2014



The evaluation of surgical results in pT0-pT1 non-small cell lung carcinoma after induction therapy
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011

Second-line therapy in elderly patients with advanced nonsmall cell lung cancer
Source: Eur Respir J 2014; 43: 240-249
Year: 2004



Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Surgical treatment of N2 non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
Source: Eur Respir Rev, 29 (158) 200035; 10.1183/16000617.0035-2020
Year: 2020



A cost minimisation comparison of five chemotherapy regimes for advanced nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 431s
Year: 2003

Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



Current challenges in the management of nonsmall cell lung cancer brain metastases
Source: Eur Respir J, 55 (1) 1901686; 10.1183/13993003.01686-2019
Year: 2020



Bronchoscopic intratumoural therapies for non-small cell lung cancer
Source: Eur Respir Rev, 29 (156) 200028; 10.1183/16000617.0028-2020
Year: 2020